Cargando…

598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients

BACKGROUND: There have been documented cases, although rare, of clinically significant infections caused by Hafnia alvei leading to infections such as bacteremia, pneumonia, UTI, meningitis, and empyema. H. alvei infections can be community-acquired or nosocomial. The published data for H. alvei in...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Keval, Shah, Heeya, Larsen, Matthew, Aslam, Sadaf, Greene, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677570/
http://dx.doi.org/10.1093/ofid/ofad500.665
_version_ 1785150161058529280
author Thakkar, Keval
Shah, Heeya
Larsen, Matthew
Aslam, Sadaf
Greene, John
author_facet Thakkar, Keval
Shah, Heeya
Larsen, Matthew
Aslam, Sadaf
Greene, John
author_sort Thakkar, Keval
collection PubMed
description BACKGROUND: There have been documented cases, although rare, of clinically significant infections caused by Hafnia alvei leading to infections such as bacteremia, pneumonia, UTI, meningitis, and empyema. H. alvei infections can be community-acquired or nosocomial. The published data for H. alvei in cancer patients is limited. The aim of this study was to characterize H. alvei infections including patient characteristics, antimicrobial susceptibility patterns, location of isolation, and microbial characteristics of isolates in cancer patients. METHODS: A retrospective cohort study was performed to review records of all consecutive patients with a positive H. alvei culture during the past 7 years. Variables included patient’s age, sex, underlying malignancy, neutrophil count, location and duration of infection, antimicrobial susceptibility patterns, hospital stay, co-isolates, and outcomes. RESULTS: A total of 15 patients with positive H. alvei cultures were identified at the Moffitt Cancer Center. There were 8 (53%) female and 7 (47%) male patients. The mean patient age was 65.7 ±15.8 yrs. All patients had underlying malignancies, most common type was solid organ malignancy in 11 patients (73%), and hematologic malignancies in 4 patients (27%). Two patients (13%) were neutropenic at the time of positive culture. H. alvei isolates were first identified in patients at a median of 8 days and an average of 11 days after admission to the hospital. Of the 15 isolates, 8 (53%) were monomicrobial and 7 (47%) were polymicrobial cultures (Table 1). Co-isolates and susceptibilities are shown in the Table 2 and 3. Table 1 [Figure: see text] Demographic data for all identified patients Table 2 [Figure: see text] Characteristics of H. alvei isolations Table 3 [Figure: see text] H. alvei antibiotic susceptibility report CONCLUSION: This study demonstrated that H. alvei is a truly rare pathogenic organism with only 15 documented cases of isolation over an 80-month time period at an academic cancer center. In patients with underlying malignancies, the organism tends to have a predilection for both the urinary tract and abdominal wounds, and can be isolated from pure cultures in the urine and with co-isolates in all other locations. Our study showed that resistance with H. alvei is usually with ampicillin and most of our isolates were resistant to cefazolin and cefoxitin. When infection does occur, isolates tend to be susceptible to standard antibiotics such as aminoglycosides and ciprofloxacin. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677570
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106775702023-11-27 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients Thakkar, Keval Shah, Heeya Larsen, Matthew Aslam, Sadaf Greene, John Open Forum Infect Dis Abstract BACKGROUND: There have been documented cases, although rare, of clinically significant infections caused by Hafnia alvei leading to infections such as bacteremia, pneumonia, UTI, meningitis, and empyema. H. alvei infections can be community-acquired or nosocomial. The published data for H. alvei in cancer patients is limited. The aim of this study was to characterize H. alvei infections including patient characteristics, antimicrobial susceptibility patterns, location of isolation, and microbial characteristics of isolates in cancer patients. METHODS: A retrospective cohort study was performed to review records of all consecutive patients with a positive H. alvei culture during the past 7 years. Variables included patient’s age, sex, underlying malignancy, neutrophil count, location and duration of infection, antimicrobial susceptibility patterns, hospital stay, co-isolates, and outcomes. RESULTS: A total of 15 patients with positive H. alvei cultures were identified at the Moffitt Cancer Center. There were 8 (53%) female and 7 (47%) male patients. The mean patient age was 65.7 ±15.8 yrs. All patients had underlying malignancies, most common type was solid organ malignancy in 11 patients (73%), and hematologic malignancies in 4 patients (27%). Two patients (13%) were neutropenic at the time of positive culture. H. alvei isolates were first identified in patients at a median of 8 days and an average of 11 days after admission to the hospital. Of the 15 isolates, 8 (53%) were monomicrobial and 7 (47%) were polymicrobial cultures (Table 1). Co-isolates and susceptibilities are shown in the Table 2 and 3. Table 1 [Figure: see text] Demographic data for all identified patients Table 2 [Figure: see text] Characteristics of H. alvei isolations Table 3 [Figure: see text] H. alvei antibiotic susceptibility report CONCLUSION: This study demonstrated that H. alvei is a truly rare pathogenic organism with only 15 documented cases of isolation over an 80-month time period at an academic cancer center. In patients with underlying malignancies, the organism tends to have a predilection for both the urinary tract and abdominal wounds, and can be isolated from pure cultures in the urine and with co-isolates in all other locations. Our study showed that resistance with H. alvei is usually with ampicillin and most of our isolates were resistant to cefazolin and cefoxitin. When infection does occur, isolates tend to be susceptible to standard antibiotics such as aminoglycosides and ciprofloxacin. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677570/ http://dx.doi.org/10.1093/ofid/ofad500.665 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Thakkar, Keval
Shah, Heeya
Larsen, Matthew
Aslam, Sadaf
Greene, John
598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title_full 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title_fullStr 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title_full_unstemmed 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title_short 598. Clinical Characteristics and Characterization of Hafnia Alvei Infections in Cancer Patients
title_sort 598. clinical characteristics and characterization of hafnia alvei infections in cancer patients
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677570/
http://dx.doi.org/10.1093/ofid/ofad500.665
work_keys_str_mv AT thakkarkeval 598clinicalcharacteristicsandcharacterizationofhafniaalveiinfectionsincancerpatients
AT shahheeya 598clinicalcharacteristicsandcharacterizationofhafniaalveiinfectionsincancerpatients
AT larsenmatthew 598clinicalcharacteristicsandcharacterizationofhafniaalveiinfectionsincancerpatients
AT aslamsadaf 598clinicalcharacteristicsandcharacterizationofhafniaalveiinfectionsincancerpatients
AT greenejohn 598clinicalcharacteristicsandcharacterizationofhafniaalveiinfectionsincancerpatients